Veletri 1.5 MG (as epoprostenol sodium) Injection
- RxCUI
- 1009216
- RxNorm name
- Veletri 1.5 MG (as epoprostenol sodium) Injection
- Display name
- Veletri 1.5 MG (as epoprostenol sodium) Injection
- Full name
- Veletri 1.5 MG (as epoprostenol sodium) Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Veletri | EPOPROSTENOL | Actelion Pharmaceuticals US, Inc. | df502787-46ec-4dd1-a2c0-be90f6d95a5d | 2022-11-28 | Warnings, Adverse reactions | 1009216 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| df502787-46ec-4dd1-a2c0-be90f6d95a5d | Veletri 1.5 MG (as epoprostenol sodium) Injection | SY | 15 | These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995 | 20221128 |
| df502787-46ec-4dd1-a2c0-be90f6d95a5d | epoprostenol 1.5 MG Injection [Veletri] | SBD | 15 | These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995 | 20221128 |
| df502787-46ec-4dd1-a2c0-be90f6d95a5d | VELETRI 1.5 MG Injection | PSN | 15 | These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995 | 20221128 |